AWM
REGN icon

Ameliora Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Ameliora Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Hold
34
– – 0.01% 181
2026
Q1 		$26.3K Hold
34
– – 0.01% 177
2025
Q4 		$26.2K Sell
34
-24
-41% -$16.3K 0.01% 178
2025
Q3 		$32.6K Sell
58
-2,319
-98% -$1.31M 0.01% 167
2025
Q2 		$1.25M Sell
2,377
-820
-26% -$458K 0.45% 39
2025
Q1 		$2.03M Sell
3,197
-44
-1% -$30.3K 0.76% 32
2024
Q4 		$2.31M Sell
3,241
-99
-3% -$83.1K 0.87% 27
2024
Q3 		$3.51M Sell
3,340
-14
-0.4% -$15.6K 1.46% 20
2024
Q2 		$3.53M Buy
3,354
+96
+3% +$93.1K 1.6% 23
2024
Q1 		$3.14M Sell
3,258
-6
-0.2% -$5.71K 1.42% 24
2023
Q4 		$2.87M Buy
3,264
+111
+4% +$91.4K 1.42% 22
2023
Q3 		$2.59M Buy
3,153
+703
+29% +$552K 1.54% 22
2023
Q2 		$1.76M Sell
2,450
-114
-4% -$87.9K 1.09% 34
2023
Q1 		$2.11M Sell
2,564
-1,163
-31% -$877K 1.23% 27
2022
Q4 		$2.69M Buy
3,727
+1,710
+85% +$1.26M 1.44% 26
2022
Q3 		$1.47M Buy
2,017
+1,960
+3,439% +$1.23M 0.8% 39
2022
Q2 		$33K Sell
57
-3,739
-98% -$2.43M 0.04% 35
2022
Q1 		$2.44M Buy
+3,796
New +$2.4M 1.6% 13

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Ameliora Wealth Management's REGN Position: Q2 2026 in Review

Ameliora Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 34 shares worth $21.2K. The position accounts for 0.01% of the portfolio, ranked #181.

Ameliora Wealth Management first reported a position in REGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.53M in Q2 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Ameliora Wealth Management held 34 shares of Regeneron Pharmaceuticals worth $21.2K as of Q2 2026.
  • Ameliora Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Ameliora Wealth Management's portfolio in Q2 2026, its #181 holding.
  • Ameliora Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Ameliora Wealth Management's Regeneron Pharmaceuticals position peaked at $3.53M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Ameliora Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.